Preview

National Journal glaucoma

Advanced search

Proxofeline in patients with mild and moderate open-angle glaucoma combined with arterial hypertension

https://doi.org/10.25700/NJG.2018.04.06

Abstract

PURPOSE: To study the efficacy of Proxofeline in patients with open-angle glaucoma and arterial hypertension.

METHODS: 32 patients (37 eyes) with mild and mode­rate open-angle glaucoma were included into the study. All patients underwent a complex ophtalmological exami­nation: visual acuity, perimetry, tonometry, tonography, gonioscopy and ophthalmoscopy before the treatment and 14 days after the treatment. All patients received Proxofeline instillation twice daily (in the morning and in the evening) and had blood pressure (BP) and heart rate measured 3 times a day.

RESULTS: After 14 days of Proxofeline instillations in­traocular pressure (IOP, P0) decreased to 14.8±1.8 mm Hg due to an increase in aqueous outflow facility (С) to 0.166±0.029 and the decrease of aqueous humor production (F) to 0.74±0.18. Becker coefficient normalization is caused by P0 decrease and aqueous humor retention reduc­tion. No changes in visual acuity, perimetric parameters or ophthalmoscopic findings were registered. A mild posi­tive IOP dynamics with a decrease by 1-2 mm Hg was note in 2 patients (7% of 28 patients). It might be due to a pro­nounced 3+/4+ anterior chamber angle pigmentation, as well as the presence of synechia that appeared after irido­cyclitis. Proxopheline instillations did not cause significant fluctuations in systemic blood pressure. No changes in pulse, systolic and diastolic pressure values were regis­tered in any patients.

CONCLUSION: Proxopheline is an effective drug for reducing IOP in patients with open-angle glaucoma. The hypotensive effect is achieved by increasing the outflow and reducing the production of aqueous humor. Additional research is needed to clarify Proxopheline efficacy in patients with secondary glaucoma caused by a pretrabecu­lar block and its influence on general hemodynamics.

About the Authors

I. B. Alekseev
Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of Russian Federation, Department of Ophthalmology.
Russian Federation

Med.Sc.D., Professor.

2/1 Barrikadnaja str., Moscow, Russian Federation, 123995.



A. I. Samoylenko
S.P. Botkin State Budgetary Hospital of the Ministry of Healthcare of Russian Federation, Branch No 1 «Eye clinic».
Russian Federation

Ph.D.

7 Mamonovskiy lane, Moscow, Russian Federation, 123001.



V. E. Belkin
S.P. Botkin State Budgetary Hospital of the Ministry of Healthcare of Russian Federation, Branch No 1 «Eye clinic».
Russian Federation

M.D.

7 Mamonovskiy lane, Moscow, Russian Federation, 123001.



O. I. Abramova
Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of Russian Federation, Department of Ophthalmology.
Russian Federation

resident.

2/1 Barrikadnaja str., Moscow, Russian Federation, 123995.



A. K. Aylarova
Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of Russian Federation, Department of Ophthalmology; S.P. Botkin State Budgetary Hospital of the Ministry of Healthcare of Russian Federation, Branch No 1 «Eye clinic».
Russian Federation

postgraduate, M.D.

2/1 Barrikadnaja str., Moscow, Russian Federation, 123995; 7 Mamonovskiy lane, Moscow, Russian Federation, 123001.



M. M. Soshina
Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of Russian Federation, Department of Ophthalmology; S.P. Botkin State Budgetary Hospital of the Ministry of Healthcare of Russian Federation, Branch No 1 «Eye clinic».
Russian Federation

postgraduate, M.D.

2/1 Barrikadnaja str., Moscow, Russian Federation, 123995; 7 Mamonovskiy lane, Moscow, Russian Federation, 123001.



References

1. Egorov E.A. Glaukoma. Natsional’noe rukovodstvo [Glaucoma. National guidelines]. Moscow: GEOTAR-Media Publ; 2013: 824 p.

2. Egorov E.A., Astahov Yu.S. Natsional’noe rukovodstvo po glaukome dlya praktikuyushchih vrachei [Glaucoma. National guide for practic¬ing doctors]. Moscow: GEOTAR-Media Publ.; 2015: 456 p. (In Russ).

3. Alyabyeva Zh.Yu., Egorov Ye.A., Tagirova S.B. The role of vascular fac¬tor in pathogenesis of glaucomatous optical neuropathy. RMJ Clinical Ophthalmology. 2002; 2:61-63. (In Russ).

4. Kurysheva N.I. Glaukomnaya opticheskaya neyropatiya [Glaucoma¬tous optic neuropathy]. Moscow: Medpress-inform Publ.; Russian Federation 2006: 136 p. (In Russ).

5. Nesterov A.P. Glaukoma [Glaucoma]. Moscow: Medical news agency MIA; 2008: 360 p. (In Russ).

6. Kunin T.A., Svirina T.A. Hemodynamics of the eyes in healthy indi¬viduals depending on the age and blood pressure level. Glaucoma. 2002; 1:10-13. (In Russ).

7. Alekseev V.N., Koroev A.O. Night hypotension as a risk factor in patients with primary open-angle glaucoma. Glaucoma. 2008; 1:30-32. (In Russ).

8. Nesterov A.P., Alyabyeva Zh.Yu. Normotensive glaucoma: modern view on pathogenesis, diagnosis, clinic and treatment. Glaucoma. 2005; 3:66-74. (In Russ).

9. Nesterov A.P. Pervichnaya glaukoma [Primary glaucoma]. Moscow, Meditsina Publ.; 1995: 242 p. (In Russ).


Review

For citations:


Alekseev I.B., Samoylenko A.I., Belkin V.E., Abramova O.I., Aylarova A.K., Soshina M.M. Proxofeline in patients with mild and moderate open-angle glaucoma combined with arterial hypertension. National Journal glaucoma. 2018;17(4):75-78. (In Russ.) https://doi.org/10.25700/NJG.2018.04.06

Views: 586


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-4104 (Print)
ISSN 2311-6862 (Online)